ETF半年度业绩出炉 哪些是“香饽饽”

Group 1 - As of June 2025, the total scale of ETFs in China has surpassed 4.31 trillion yuan, reflecting a year-to-date growth of 15.58% [3] - Stock ETFs have seen a net inflow of 144.9 billion yuan this year, exceeding 3 trillion yuan in total scale, while bond ETFs have grown by 120.71% to reach 383.98 billion yuan [3] - The credit bond ETF market has experienced significant growth, with a net inflow of 109.09 billion yuan in the first half of the year, accounting for half of the total bond ETF scale [3][4] Group 2 - The average return of all ETFs in the market for the first half of the year is 6.08%, with Hong Kong stock ETFs performing particularly well, dominating the top 50 performing ETFs [5] - Ten ETFs have achieved returns exceeding 50%, primarily in the innovative drug and biotechnology sectors, with the top performer being the Huatai-PB Hong Kong Stock Connect Innovative Drug ETF at 58.77% [5] - The innovative drug sector is experiencing a new wave of growth driven by policy support and technological breakthroughs, with significant increases in stock prices for many Hong Kong-listed pharmaceutical companies [5][9] Group 3 - The technology and gold ETFs have also shown strong performance, with returns concentrated above 20%, while 13 ETFs have reported losses exceeding 10%, mainly in the photovoltaic and energy sectors [6] - Analysts are focusing on sectors such as innovative drugs, technology growth, and new consumption for future investment opportunities [8][9] - The new consumption sector is expected to see investment opportunities shift between growth styles and high-dividend styles, influenced by changing consumer preferences among Generation Z [10]